S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC
Pharmacy Focus30 Juli 2025

S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.

Avsnitt(336)

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
rss-jossan-nina
sexnoveller-deluxe
alska-oss
angestpodden
not-fanny-anymore
johannes-hansen-podcast
rss-vuxna-pa-latsas
vinterpasset
sova-med-dan-horning
rss-viktmedicinpodden
rss-the-house-podcast-3
rss-sjalsligt-avkladd
sa-in-i-sjalen
rss-basta-livet
smartare-fitness-podden
brottarbroder
rss-the-house-podcast-4